专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US10597608B2 Cetylated fatty acids, system for the preparation thereof and use thereof 有权
公开(公告)号：US10597608B2
公开(公告)日：2020-03-24
申请号：US15750485
申请日：2016-08-09
申请人： Pharmanutra S.P.A.
发明人： Andrea Lacorte , Germano Tarantino , Paolo Bondioli
IPC分类号： C11C3/00 , C07C67/08 , A61K31/23 , C07C69/24 , A61P37/02 , A61P9/00 , A61P19/02
摘要： The present invention relates to a process for preparing a mixture of cetylated fatty acids and a system for carrying out said process. Furthermore, the present invention relates to a composition comprising, or alternatively, consisting of said mixture of cetylated fatty acids. Finally, the present invention relates to said composition for use in the treatment and/or prevention of: (i) rheumatoid arthritis of inflammatory and non-inflammatory origin, in particular osteoarthritis; (ii) other inflammatory joint conditions; (iii) psoriasis, lupus, periodontal diseases or cardiovascular or heart diseases; (iv) all post-traumatic osteoarticular pathologies including sports injuries; (v) all degenerative joint pathologies (arthrosis, gonarthrosis, coxarthrosis, etc.), and (vi) inflammatory-traumatic tendon and muscular conditions. Furthermore, it is envisaged that the composition of the present invention be used in the treatment and/or prevention of the above-mentioned pathologies and disorders (i)-(vi) in association with a rehabilitative therapy. The composition comprising said mixture is formulated in a pharmaceutical form for oral use (novel food, supplement or medical device), i.e. in the form of a pill, pastille, capsule, tablet, granules, dispersible powder, syrup, solution or sprayable solution; for topical use, i.e. in the form of a cream, unguent, ointment, gel or spray to be used as such for application on the skin, or else for trans dermal use in the form of a patch.

2. 发明申请

US20200246377A1 COMPOSITION FOR USE IN THE PREVENTION AND IN THE TREATMENT OF IRON DEFICIENCY 审中-公开
公开(公告)号：US20200246377A1
公开(公告)日：2020-08-06
申请号：US16635516
申请日：2018-07-27
申请人： PHARMANUTRA S.P.A.
发明人： Andrea LACORTE , Germano TARANTINO
IPC分类号： A61K33/26 , A23L33/155 , A23L33/16 , A23L33/00 , A61K31/593 , A61K9/00 , A61P29/00
摘要： The present invention relates to a composition for use in a method for the preventive or curative treatment of an iron deficiency and pathologies and disorders connected thereto in a subject, wherein said use comprises the administration of the composition to said subject.

3. 发明申请

US20220226274A1 COMPOSITIONS COMPRISING CETYLATED FATTY ACIDS FOR USE IN THE TREATMENT OF GASTRIC MUCOSA, DIABETES AND HIGH BLOOD GLUCOSE LEVELS 有权
公开(公告)号：US20220226274A1
公开(公告)日：2022-07-21
申请号：US17613719
申请日：2020-05-27
申请人： ALESCO S.R.L. , PHARMANUTRA S.P.A.
发明人： Andrea LACORTE , Germano TARANTINO , Elisa BRILLI
IPC分类号： A61K31/231 , A61K47/10 , A61P1/04
摘要： A composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and an antioxidant in reduced percentages by weight, and related methods for treatment of arthritis and of inflammatory joint and musculoskeletal pain. Furthermore a composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and, optionally, an antioxidant, and related treatment methods for protecting the gastric mucosa and for regulating the blood glucose levels. Additionally, a method is described for preparing the at least one cetylated fatty acid or mixture of cetylated fatty acids and for preparing compositions comprising the cetylated fatty acids and the antioxidant.

4. 发明申请

US20190016991A1 CETYLATED FATTY ACIDS, SYSTEM FOR THE PREPARATION THEREOF AND USE THEREOF 审中-公开
公开(公告)号：US20190016991A1
公开(公告)日：2019-01-17
申请号：US15750485
申请日：2016-08-09
申请人： Pharmanutra S.P.A.
发明人： Andrea Lacorte , Germano Tarantino , Paolo Bondioli
IPC分类号： C11C3/00
摘要： The present invention relates to a process for preparing a mixture of cetylated fatty acids and a system for carrying out said process. Furthermore, the present invention relates to a composition comprising, or alternatively, consisting of said mixture of cetylated fatty acids. Finally, the present invention relates to said composition for use in the treatment and/or prevention of: (i) rheumatoid arthritis of inflammatory and non-inflammatory origin, in particular osteoarthritis; (ii) other inflammatory joint conditions; (iii) psoriasis, lupus, periodontal diseases or cardiovascular or heart diseases; (iv) all post-traumatic osteoarticular pathologies including sports injuries; (v) all degenerative joint pathologies (arthrosis, gonarthrosis, coxarthrosis, etc.), and (vi) inflammatory-traumatic tendon and muscular conditions. Furthermore, it is envisaged that the composition of the present invention be used in the treatment and/or prevention of the above-mentioned pathologies and disorders (i)-(vi) in association with a rehabilitative therapy. The composition comprising said mixture is formulated in a pharmaceutical form for oral use (novel food, supplement or medical device), i.e. in the form of a pill, pastille, capsule, tablet, granules, dispersible powder, syrup, solution or sprayable solution; for topical use, i.e. in the form of a cream, unguent, ointment, gel or spray to be used as such for application on the skin, or else for trans dermal use in the form of a patch.

5. 发明公开

US20240139235A1 IRON(III) FORMULATIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION 审中-公开
公开(公告)号：US20240139235A1
公开(公告)日：2024-05-02
申请号：US18279039
申请日：2022-03-14
申请人： PHARMANUTRA S.P.A.
发明人： Andrea LACORTE , Germano TARANTINO , Elisa BRILLI
IPC分类号： A61K33/26 , A61K33/42 , A61K47/24 , A61K47/26 , A61K47/36 , A61P1/04
CPC分类号： A61K33/26 , A61K33/42 , A61K47/24 , A61K47/26 , A61K47/36 , A61P1/04
摘要： The present invention relates to an iron-based formulation and compositions thereof for use in a method for the treatment of a gastrointestinal inflammation, in a therapeutic or non-therapeutic treatment of an iron deficiency by administering said formulation to a subject, wherein said iron formulation is capable of reducing (or maintaining constant) the amount of pathogenic bacteria present in the gut microbiota of the treated subject and, preferably, also capable of increasing the variety of the gut microbiota of the treated subject.

6. 发明授权

US11186536B2 Cetylated fatty acids, system for the preparation thereof and use thereof 有权
公开(公告)号：US11186536B2
公开(公告)日：2021-11-30
申请号：US16789289
申请日：2020-02-12
申请人： Pharmanutra S.P.A.
发明人： Andrea Lacorte , Germano Tarantino , Paolo Bondioli
IPC分类号： C07C69/24 , A61K31/23 , C07C67/08 , C11C3/00 , A61P37/02 , A61P9/00 , A61P19/02
摘要： The present invention relates to a process for preparing a mixture of cetylated fatty acids and a system for carrying out said process. Furthermore, the present invention relates to a composition comprising, or alternatively, consisting of said mixture of cetylated fatty acids. Finally, the present invention relates to said composition for use in the treatment and/or prevention of: (i) rheumatoid arthritis of inflammatory and non-inflammatory origin, in particular osteoarthritis; (ii) other inflammatory joint conditions; (iii) psoriasis, lupus, periodontal diseases or cardiovascular or heart diseases; (iv) all post-traumatic osteoarticular pathologies including sports injuries; (v) all degenerative joint pathologies (arthrosis, gonarthrosis, coxarthrosis, etc.), and (vi) inflammatory-traumatic tendon and muscular conditions. Furthermore, it is envisaged that the composition of the present invention be used in the treatment and/or prevention of the above-mentioned pathologies and disorders (i)-(vi) in association with a rehabilitative therapy. The composition comprising said mixture is formulated in a pharmaceutical form for oral use (novel food, supplement or medical device), i.e. in the form of a pill, pastille, capsule, tablet, granules, dispersible powder, syrup, solution or sprayable solution; for topical use, i.e. in the form of a cream, unguent, ointment, gel or spray to be used as such for application on the skin, or else for transdermal use in the form of a patch.

7. 发明申请

US20220220414A1 METHOD FOR PREPARING A COMPOSITION COMPRISING CETYLATED FATTY ACIDS 有权
公开(公告)号：US20220220414A1
公开(公告)日：2022-07-14
申请号：US17613886
申请日：2020-05-27
申请人： ALESCO S.R.L. , PHARMANUTRA S.P.A.
发明人： Andrea LACORTE , Germano TARANTINO , Elisa BRILLI
IPC分类号： C11C3/00 , C11C1/08
摘要： A composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and an antioxidant in reduced percentages by weight, and related methods for treatment of arthritis and of inflammatory joint and musculoskeletal pain. Furthermore a composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and, optionally, an antioxidant, and related treatment methods for protecting the gastric mucosa and for regulating the blood glucose levels. Additionally, a method is described for preparing the at least one cetylated fatty acid or mixture of cetylated fatty acids and for preparing compositions comprising the cetylated fatty acids and the antioxidant.

8. 发明申请

US20220211655A1 COMPOSITIONS COMPRISING CETYLATED FATTY ACIDS AND USE THEREOF IN THE TREATMENT OF ARTHRITIS AND JOINT INFLAMMATORY CONDITIONS 有权
公开(公告)号：US20220211655A1
公开(公告)日：2022-07-07
申请号：US17614294
申请日：2020-05-27
申请人： ALESCO S.R.L. , PHARMANUTRA S.P.A.
发明人： Andrea LACORTE , Germano TARANTINO , Elisa BRILLI
IPC分类号： A61K31/231 , A61K31/23 , A61K31/122 , A61K31/355 , A61K31/685 , A61K36/537 , A61K31/05 , A61K47/44 , A61P29/00
摘要： A composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and an antioxidant in reduced percentages by weight, and related methods for treatment of arthritis and of inflammatory joint and musculoskeletal pain. Furthermore a composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and, optionally, an antioxidant, and related treatment methods for protecting the gastric mucosa and for regulating the blood glucose levels. Additionally, a method is described for preparing the at least one cetylated fatty acid or mixture of cetylated fatty acids and for preparing compositions comprising the cetylated fatty acids and the antioxidant.

9. 发明申请

US20200206157A1 COMPOSITION FOR USE IN THE PREVENTION AND TREATMENT OF PATHOLOGIES OF THE CARDIOVASCULAR APPARATUS 审中-公开
公开(公告)号：US20200206157A1
公开(公告)日：2020-07-02
申请号：US16631426
申请日：2018-07-26
申请人： PHARMANUTRA S.P.A.
发明人： Andrea LACORTE , Germano TARANTINO , Elisa BRILLI
IPC分类号： A61K31/122 , A61K33/06 , A61K33/26 , A61K47/36 , A61P9/00 , A23L33/15
摘要： The present invention relates to a composition comprising or, alternatively, consisting of an effective amount of a mixture comprising at least (a) one lipophilic vitamin, or analogues and derivatives thereof, (b) one magnesium salt and (c) one iron (III) oxide, complex or salt for use in a preventive or curative method for treating cardiovascular disorders and pathologies.

10. 发明申请

US20200181530A1 CETYLATED FATTY ACIDS, SYSTEM FOR THE PREPARATION THEREOF AND USE THEREOF 审中-公开
公开(公告)号：US20200181530A1
公开(公告)日：2020-06-11
申请号：US16789289
申请日：2020-02-12
申请人： Pharmanutra S.P.A.
发明人： Andrea Lacorte , Germano Tarantino , Paolo Bondioli
IPC分类号： C11C3/00 , C07C69/24 , A61K31/23 , C07C67/08
摘要： The present invention relates to a process for preparing a mixture of cetylated fatty acids and a system for carrying out said process. Furthermore, the present invention relates to a composition comprising, or alternatively, consisting of said mixture of cetylated fatty acids. Finally, the present invention relates to said composition for use in the treatment and/or prevention of: (i) rheumatoid arthritis of inflammatory and non-inflammatory origin, in particular osteoarthritis; (ii) other inflammatory joint conditions; (iii) psoriasis, lupus, periodontal diseases or cardiovascular or heart diseases; (iv) all post-traumatic osteoarticular pathologies including sports injuries; (v) all degenerative joint pathologies (arthrosis, gonarthrosis, coxarthrosis, etc.), and (vi) inflammatory-traumatic tendon and muscular conditions. Furthermore, it is envisaged that the composition of the present invention be used in the treatment and/or prevention of the above-mentioned pathologies and disorders (i)-(vi) in association with a rehabilitative therapy. The composition comprising said mixture is formulated in a pharmaceutical form for oral use (novel food, supplement or medical device), i.e. in the form of a pill, pastille, capsule, tablet, granules, dispersible powder, syrup, solution or sprayable solution; for topical use, i.e. in the form of a cream, unguent, ointment, gel or spray to be used as such for application on the skin, or else for transdermal use in the form of a patch.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式